WEDGE CAPITAL MANAGEMENT L L P/NC
Position in BMY — Bristol Myers Squibb Co
CIK 1015308
CHARLOTTE, NC
Position in BMY
as of Jun 30, 2026
· filed Jul 10, 2026
Position Value
$30,426,644
+$527,104 QoQ
Shares Held
528,057
+7.1% QoQ
Ownership
0.026%
of shares outstanding
% of Portfolio
0.51%
of 13F equity value
Holder Rank
#225
of 2,506 holders
Holding Since
Mar 2021
21 quarters on record
Voting authority
Sole 72%
Shared 0%
None 28%
Common Shares in BMY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026WEDGE CAPITAL MANAGEMENT L L P/NC holds $67,797,573 across 8 Drug Manufacturers - General names. BMY ranks #2 (44.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABBV |
AbbVie Inc.
|
134,579 | $33,865,459 | |
| 2 | BMY |
Bristol Myers Squibb Co
This page
|
528,057 | $30,426,644 | |
| 3 | JNJ |
Johnson & Johnson
|
4,295 | $1,090,801 | |
| 4 | LLY |
ELI LILLY & Co
|
764 | $916,364 | |
| 5 | MRK |
Merck & Co., Inc.
|
4,873 | $626,180 | |
| 6 | PFE |
Pfizer Inc
|
13,423 | $323,225 | |
| 7 | AMGN |
Amgen Inc
|
840 | $304,180 | |
| 8 | GILD |
Gilead Sciences, Inc.
|
1,937 | $244,720 |
All Filings in BMY
Export CSV
21 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $30,426,644 | 528,057 | Shares | Sole | 2026-07-10 | |
| 2026-03-31 | $29,899,540 | 492,985 | Shares | Sole | 2026-04-13 | |
| 2025-12-31 | $30,390,335 | 563,410 | Shares | Sole | 2026-01-14 | |
| 2025-09-30 | $26,415,791 | 585,716 | Shares | Sole | 2025-10-10 | |
| 2025-06-30 | $28,426,689 | 614,100 | Shares | Sole | 2025-07-11 | |
| 2025-03-31 | $244,813 | 4,014 | Shares | Sole | 2025-04-14 | |
| 2024-12-31 | $29,150,910 | 515,398 | Shares | Sole | 2025-01-15 | |
| 2024-09-30 | $33,026,780 | 638,322 | Shares | Sole | 2024-10-11 | |
| 2024-03-31 | $246,963 | 4,554 | Shares | Sole | 2024-04-23 | |
| 2023-12-31 | $228,842 | 4,460 | Shares | Sole | 2024-02-01 | |
| 2023-09-30 | $258,684 | 4,457 | Shares | Sole | 2023-10-13 | |
| 2023-06-30 | $30,697,215 | 480,019 | Shares | Sole | 2023-07-17 | |
| 2023-03-31 | $38,144,481 | 550,346 | Shares | Sole | 2023-04-11 | |
| 2022-12-31 | $35,823,473 | 497,894 | Shares | Sole | 2023-01-17 | |
| 2022-09-30 | $36,335,449 | 511,119 | Shares | Sole | 2022-10-13 | |
| 2022-06-30 | $37,393,202 | 485,626 | Shares | Sole | 2022-07-11 | |
| 2022-03-31 | $37,123,558 | 508,333 | Shares | Sole | 2022-04-12 | |
| 2021-12-31 | $34,213,564 | 548,734 | Shares | Sole | 2022-01-24 | |
| 2021-09-30 | $30,246,757 | 511,184 | Shares | Sole | 2021-10-14 | |
| 2021-06-30 | $295,143 | 4,417 | Shares | Sole | 2021-07-14 | |
| 2021-03-31 | $343,048 | 5,434 | Shares | Sole | 2021-04-12 | |
| No filing history on record for this holder in this stock. | ||||||